Sirius Medical raised €10 million in funding on World Cancer Day, led by Invest-NL and Nextgen Ventures, to enhance its cancer care technology and expand market reach.
Target Information
Sirius Medical, a prominent medical technology company and a leader in oncological surgical marker navigation, has successfully secured €10 million in funding on World Cancer Day, February 4, 2025. This funding round was spearheaded by Invest-NL and Nextgen Ventures, with participation from De Groot Family Office and existing investors including Brabantse Ontwikkelings Maatschappij (BOM), Holland Capital, Curie Capital, Team Holmium, and the Sirius Medical team.
This milestone not only marks a significant moment in Sirius Medical’s journey but underscores the company's commitment to enhancing cancer care globally. Their flagship product, the Sirius Pintuition® surgical navigation platform, is highly regarded among breast cancer surgeons for its innovative and user-friendly wireless localization solution used in breast-conserving surgeries across various hospitals.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Netherlands
The medical technology industry in the Netherlands is robust and innovative, known for its strong emphasis on research and development. The country boasts a dynamic landscape characterized by close collaborations between hospitals, universi
Similar Deals
LUMO Labs and Graduate Entrepreneur → Surgical Reality
2025
Invest-NL
invested in
Sirius Medical
in 2025
in a Other VC deal
Disclosed details
Transaction Size: $10M